Thrombolysis in Early Acute Ischemic Stroke Trial-Blood Pressure Management

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 340 participants.

Also called NCT07279259

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 340 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07279259
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07279259. Randomized; single masking; primary purpose treatment. Start 2026-01-15 (anticipated); primary completion 2027-12-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Thrombolysis in Early Acute Ischemic Stroke Trial-Blood Pressure Management
Acronym
EAST-BP
Condition
Stroke
Condition
Acute Ischemic Stroke
Condition
Thrombolysis
Intervention (Procedure)
Adjusted BP management group
Intervention (Procedure)
Usual BP management group
Lead sponsor
Shanghai East Hospital (class: other)
Collaborator
Shanghai 7th People's Hospital (class: other)

Record details

Record id
cardio:ct-nct07279259
Content hash
7787746a9fe3cf251f010ad5bdd3e0d7739e1499c8a77afdbbd1254d2b25b5c1